GDTC
CytoMed TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About GDTC
Cytomed Therapeutics Ltd
A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers
1 Commonwealth Lane, #08-22, Singapore 149544
--
CytoMed Therapeutics Ltd was incorporated in Singapore on March 8, 2018. The company is a preclinical biopharmaceutical company focused on leveraging the company's proprietary technology to create novel cellular immunotherapies for the treatment of human cancer. The development of the company's new technology is inspired by the clinical success of existing CAR-T cells in the treatment of hematological malignancies, as well as the current clinical limitations and commercial challenges of applying CAR-T principles to the treatment of solid tumors.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
